Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. 2022

Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Clostridioides difficile is a Gram-positive anaerobe that can cause a spectrum of disorders that range in severity from mild diarrhoea to fulminant colitis and/or death. The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea. In this Review, we highlight recent biochemical and structural advances in our understanding of the mechanisms that govern host-toxin interactions. Understanding how C. difficile toxins affect the host forms a foundation for developing novel strategies for treatment and prevention of C. difficile infection.

UI MeSH Term Description Entries
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000992 Antitoxins Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS. Antitoxin
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D016360 Clostridioides difficile A common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy. Clostridium difficile

Related Publications

Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
September 2021, Expert review of anti-infective therapy,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
January 2019, Therapeutic advances in infectious disease,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
June 2023, Gastroenterology & hepatology,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
June 2023, Gastroenterology & hepatology,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
February 2023, The FEBS journal,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
January 2024, The American journal of gastroenterology,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
January 2023, Expert review of gastroenterology & hepatology,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
January 2024, Advances in experimental medicine and biology,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
January 2021, Frontiers in microbiology,
Shannon L Kordus, and Audrey K Thomas, and D Borden Lacy
January 2021, Frontiers in pharmacology,
Copied contents to your clipboard!